SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-307368
Filing Date
2020-12-01
Accepted
2020-12-01 17:21:32
Documents
15
Period of Report
2020-11-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d17010d8k.htm   iXBRL 8-K 31916
2 EX-1.1 d17010dex11.htm EX-1.1 207478
3 EX-5.1 d17010dex51.htm EX-5.1 8977
7 GRAPHIC g17010g1201104322543.jpg GRAPHIC 2605
  Complete submission text file 0001193125-20-307368.txt   442825

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA acet-20201130.xsd EX-101.SCH 3072
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE acet-20201130_lab.xml EX-101.LAB 18887
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acet-20201130_pre.xml EX-101.PRE 11861
8 EXTRACTED XBRL INSTANCE DOCUMENT d17010d8k_htm.xml XML 3468
Mailing Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116
Business Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

IRS No.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38359 | Film No.: 201361706
SIC: 2834 Pharmaceutical Preparations